Literature DB >> 14627639

Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32.

Charles K Abrams1, Mona Freidin, Feliksas Bukauskas, Kostantin Dobrenis, Thaddeus A Bargiello, Vytas K Verselis, Michael V L Bennett, Lei Chen, Zarife Sahenk.   

Abstract

X-linked Charcot-Marie-Tooth disease is an inherited peripheral neuropathy arising in patients with mutations in the gene encoding connexin 32 (Cx32). Cx32 is expressed at the paranodes and Schmidt-Lantermann incisures of myelinating Schwann cells in which it is believed to form a reflexive pathway between the abaxonal and adaxonal cytoplasmic domains. Patients with the Val181Ala (V181A) mutation have a severe peripheral neuropathy. Experiments using a nude mouse xenograft system show that Schwann cells expressing only this mutant form of Cx32 are profoundly impaired in their ability to support the earliest stages of regeneration of myelinated fibers. Coupling between paired Xenopus oocytes expressing V181A is reduced compared with the coupling between oocytes expressing wild-type human Cx32 (32WT), and protein levels assayed by Western blot are substantially lower. Immunocytochemisty shows that Neuro2a cells expressing the V181A mutant have very few gap junction plaques compared with cells expressing 32WT; Cx32 protein levels are lower in these cells than in those expressing 32WT. Because failure of normal regeneration is evident before formation of myelin, loss of function of Cx32 may impact on the function of precursors of the myelinating Schwann cell before the formation of the hypothesized reflexive pathway. The Glu102Gly (E102G) mutation leads to a milder phenotype. Early regeneration is normal in grafts with Schwann cells expressing the E102G mutant. The only abnormality detected in the behavior of its channel is increased sensitivity to acidification-induced closure, a property that may lead to reduced gap junction coupling during periods of metabolic stress. This restricted functional abnormality may explain the relatively mild phenotype seen in the xenograft model and in E102G patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14627639      PMCID: PMC4513672     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  37 in total

1.  Molecular analysis of voltage dependence of heterotypic gap junctions formed by connexins 26 and 32.

Authors:  J B Rubin; V K Verselis; M V Bennett; T A Bargiello
Journal:  Biophys J       Date:  1992-04       Impact factor: 4.033

2.  X-linked dominant Charcot-Marie-Tooth disease: nerve biopsies allow morphological evaluation and detection of connexin32 mutations (Arg15Trp, Arg22Gln).

Authors:  J Senderek; C Bergmann; S Quasthoff; V T Ramaekers; J M Schröder
Journal:  Acta Neuropathol       Date:  1998-05       Impact factor: 17.088

3.  Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties.

Authors:  C Ressot; D Gomès; A Dautigny; D Pham-Dinh; R Bruzzone
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

4.  Altered connexin expression after peripheral nerve injury.

Authors:  K J Chandross; J A Kessler; R I Cohen; E Simburger; D C Spray; P Bieri; R Dermietzel
Journal:  Mol Cell Neurosci       Date:  1996-06       Impact factor: 4.314

5.  A quantitative study of anterior root fibres during early myelination. II. Longitudinal variation in sheath thickness and axon circumference.

Authors:  J P Fraher
Journal:  J Anat       Date:  1973-09       Impact factor: 2.610

6.  The mouse gap junction gene connexin29 is highly expressed in sciatic nerve and regulated during brain development.

Authors:  G Söhl; J Eiberger; Y T Jung; C A Kozak; K Willecke
Journal:  Biol Chem       Date:  2001-06       Impact factor: 3.915

7.  X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations(1).

Authors:  J Senderek; B Hermanns; C Bergmann; B Boroojerdi; M Bajbouj; M Hungs; V T Ramaekers; S Quasthoff; D Karch; J M Schröder
Journal:  J Neurol Sci       Date:  1999-08-15       Impact factor: 3.181

8.  Development of myelinated nerve fibers in the sixth cranial nerve of the rat: a quantitative electron microscope study.

Authors:  A F Hahn; Y Chang; H D Webster
Journal:  J Comp Neurol       Date:  1987-06-22       Impact factor: 3.215

9.  Putative gap junctional communication between axon and regenerating Schwann cells during mammalian peripheral nerve regeneration.

Authors:  M Dezawa; T Mutoh; A Dezawa; E Adachi-Usami
Journal:  Neuroscience       Date:  1998-08       Impact factor: 3.590

10.  Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenografts.

Authors:  Zarife Sahenk; Carmen Serrano-Munuera; Lei Chen; Inga Kakabadze; Haikady N Najagara
Journal:  J Peripher Nerv Syst       Date:  2003-06       Impact factor: 3.494

View more
  22 in total

Review 1.  Roles of gap junctions and connexins in non-neoplastic pathological processes in which cell proliferation is involved.

Authors:  Maria Lúcia Zaidan Dagli; Francisco Javier Hernandez-Blazquez
Journal:  J Membr Biol       Date:  2007-07-25       Impact factor: 1.843

Review 2.  Gap junctions in inherited human disorders of the central nervous system.

Authors:  Charles K Abrams; Steven S Scherer
Journal:  Biochim Biophys Acta       Date:  2011-08-16

3.  Molecular genetics of charcot-marie-tooth disease: from genes to genomes.

Authors:  H Azzedine; J Senderek; C Rivolta; R Chrast
Journal:  Mol Syndromol       Date:  2012-10-12

4.  Post-translational modifications of connexin26 revealed by mass spectrometry.

Authors:  Darren Locke; Shengjie Bian; Hong Li; Andrew L Harris
Journal:  Biochem J       Date:  2009-12-10       Impact factor: 3.857

5.  Connexin 32 increases the proliferative response of Schwann cells to neuregulin-1 (Nrg1).

Authors:  Mona Freidin; Samantha Asche; Thaddeus A Bargiello; Michael V L Bennett; Charles K Abrams
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

6.  Human oligodendrocytes express Cx31.3: function and interactions with Cx32 mutants.

Authors:  Irene Sargiannidou; Meejin Ahn; Alan D Enriquez; Alejandro Peinado; Richard Reynolds; Charles Abrams; Steven S Scherer; Kleopas A Kleopa
Journal:  Neurobiol Dis       Date:  2008-02-15       Impact factor: 5.996

7.  Functional requirement for a highly conserved charged residue at position 75 in the gap junction protein connexin 32.

Authors:  Charles K Abrams; Mahee Islam; Rola Mahmoud; Taekyung Kwon; Thaddeus A Bargiello; Mona M Freidin
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

8.  Cx29 and Cx32, two connexins expressed by myelinating glia, do not interact and are functionally distinct.

Authors:  Meejin Ahn; Jonathan Lee; Andreas Gustafsson; Alan Enriquez; Eric Lancaster; Jai-Yoon Sul; Philip G Haydon; David L Paul; Yan Huang; Charles K Abrams; Steven S Scherer
Journal:  J Neurosci Res       Date:  2008-04       Impact factor: 4.164

9.  CNS involvement in CMTX1 caused by a novel connexin 32 mutation: a 6-year follow-up in neuroimaging and nerve conduction.

Authors:  Chong Xie; Xiajun Zhou; Desheng Zhu; Wei Liu; Xiaoqing Wang; Hong Yang; Zezhi Li; Yong Hao; Guang-Xian Zhang; Yangtai Guan
Journal:  Neurol Sci       Date:  2016-04-20       Impact factor: 3.307

10.  Properties of human connexin 31, which is implicated in hereditary dermatological disease and deafness.

Authors:  Charles K Abrams; Mona M Freidin; Vytas K Verselis; Thaddeus A Bargiello; David P Kelsell; Gabriele Richard; Michael V L Bennett; Feliksas F Bukauskas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.